Table 3

Change from baseline in difficulty in swallowing^a and sore throat relief^b at the end of day 1, at 24 hours post-first dose, and at the end of days 2 and 3; intent-to-treat population

	Difficulty in swallowing			Sore throat relief
	Difference between least squares means^c	95% CI	P-value for treatment	Difference between least squares means^a	95% CI	P-value for treatment
End of day 1	–5.55	–10.15 to –0.94	0.018	0.42	0.05 to 0.80	0.026
24 hours post-first dose	–4.31	–8.79 to 0.16	0.059	0.28	–0.10 to 0.66	0.150
End of day 2	–5.74	–10.39 to –1.09	0.016	0.33	–0.06 to 0.73	0.101
End of day 3	–5.12	–9.80 to –0.43	0.032	0.38	–0.04 to 0.79	0.078

↵a Measured on 100 mm visual analogue scale where 0 mm = no difficulty, 100 mm = very difficult.
↵b Measured on a 7-point scale where 0 = no relief, 6 = complete relief.
↵c Flurbiprofen 8.75 mg microgranules minus placebo.